AP30ETF vs SBI Innovative Opportunities Fund

Portfolio Overlap Analysis · ICICI vs SBI

12.4%
Low Overlap
4 common stocks · Rank #17589 of 28,292 pairs
Fund A
AP30ETF
ICICI · Equity - Other

Common Holdings (4)

StockWt% in AP30ETFWt% in SBI Innovative OpportunitiesOverlap
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
3.87%3.75%3.75%
Bajaj Finance Ltd.
Finance
3.31%3.37%3.31%
Lupin Ltd.
Pharmaceuticals & Biotechnology
2.78%2.77%2.77%
Bajaj Finserv Ltd.
Finance
2.61%3.27%2.61%

Unique to AP30ETF

  • ICICI Bank Ltd.4.62%
  • HDFC Bank Ltd.4.48%
  • Apollo Hospitals Enterprise Ltd.4.36%
  • ITC Ltd.4.19%
  • Sun Pharmaceutical Industries Ltd.4.15%
  • HDFC Life Insurance Company Ltd.3.96%
  • Bharti Airtel Ltd.3.88%
  • Britannia Industries Ltd.3.87%
  • Dr. Reddy's Laboratories Ltd.3.71%

Unique to SBI Innovative Opportunities

  • Eternal Ltd.7.93%
  • TBO Tek Ltd.6.91%
  • BlackBuck Ltd.5.86%
  • Ather Energy Ltd.4.47%
  • FSN E-Commerce Ventures Ltd.4.27%
  • Meesho Ltd.3.83%
  • Honeywell Automation India Ltd.3.54%
  • Firstsource Solutions Ltd.3.38%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
6.5% (2)
Finance
5.9% (2)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for AP30ETF

More comparisons for SBI Innovative Opportunities

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.